GSK-IPF116711

Study Sponsor: GSK

Study Title

A randomised, placebo-controlled, double-blind, repeat dose escalation study with GSK2126458 in patients with Idiopathic Pulmonary Fibrosis (IPF)

Medicine or Vaccine (generic name)

omipalisib

Sponsor Identification Number

IPF116711

Trial Registry Identification Number(#'s)

NCT01725139 2012-001376-11

Medical Condition

Idiopathic Pulmonary Fibrosis

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

September 2019